Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Biostage Inc (BSTG)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
5.000 0.000    0.00%
04/08 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 208
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 5.000 - 5.000
Biostage 5.000 0.000 0.00%
IndustryBiotechnology
SectorHealthcare
Employees

10

Equity Type

ORD

Biostage, Inc. is a clinical-stage biotechnology company that uses cell therapy to regenerate organs inside the human body to treat cancer, trauma and birth defects. The Company's Cellframe technology uses the patient’s own stem cells from a simple adipose/fat tissue biopsy, expanded and banked, and then seeded onto a scaffold that mimics the natural dimensions of the organ being regenerated. Its product candidates include Cellspan esophageal implants, Cellspan bronchial implants and Cellspan tracheal implants. It is focused on developing its Cellspan esophageal implant for the treatment of esophageal atresia. Its esophageal implant consists of a hollow, tubular scaffold consisting of thin fibers of plastic made in the shape of the esophagus. Its Cellspan bronchial implants enable the surgeon to preserve the lung and repair the bronchus after surgical resection without debilitating outcomes and complications.

Contact Information

Phone 774 233 7300
Fax 774 233 7302

Top Executives

Name Age Since Title
Jason Jing Chen 59 2018 Vice Chairman
Charles S. Cox - 2018 Member of Scientific Advisory Board
Joseph Philip Vacanti 73 2015 Co-Chairman of Scientific Advisory Board
James E. Shmerling 68 2018 Independent Director
Ting Li 45 2018 Independent Director
Stephen F. Badylak - - Co-Chairman of Scientific Advisory Board
Junli He 48 2021 Independent Director
Christine Finck - 2018 Member of Scientific Advisory Board
Herman Sanchez 46 2021 Independent Director
David Green 58 2012 Interim CEO & Chairman
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BSTG Comments

Write your thoughts about Biostage Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email